Lafutidine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A02BA08
CAS registry number (Chemical Abstracts Service)
0118288-08-7
Chemical Formula
C22-H29-N3-O4-S
Molecular Weight
431
Therapeutic Categories
Histamine H₂-receptor antagonist
Treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD)
Chemical Names
(±)-2-(furfurylsulfinyl)-N-[(Z)-4-[[4-(piperidinomethyl)-2-pyridyl]oxy]-2-butenyl]acetamide (WHO)
(Z)-2-[(2-Furanylmethyl)sulfinyl]-N-[4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-butenyl]-acetamide
2-[(2-Furanylmethyl)-sulfinyl]-N-[(2Z)4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-butenyl]-acetamide
Foreign Names
- Lafutidinum (Latin)
- Lafutidin (German)
- Lafutidine (French)
- Lafutidina (Spanish)
Generic Names
- Lafutidine (OS: JAN)
- FRG-8813 (IS)
- Loctidine (IS)
- UNII-49S4O7ADLC (IS)
Brand Names
- He Ke Di Si
Guorui Pharmaceutical, China - Lemeiting
Sibao Pharmaceutical, China - Ning Wei Shu
Guofeng Pharmaceutical, China - Protecadin
Taiho Yakuhin, Japan - Shun Ru
Runbang Pharmaceutical, China - Stogar
UCB Japan, Japan - Weisida
Double-Crane, China
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
